Results 171 to 180 of about 153,974 (268)

Opportunities for Digital Health to Support Early Psychosis Care in Ghana: Qualitative Study Among Patients, Caregivers, and Clinicians. [PDF]

JMIR Form Res
Larsen A, Agorinya J, Beaulieu A, Attah DA, Tauscher J, Asafo S, Buck B, Sottie EQ, DeVries E, Okyere AF, Ampaw M, Duah CA, Ofori-Atta A, Obeng K, Ben-Zeev D.   +14 more
europepmc   +1 more source

Perspective: Depression in Persons with Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Depression is a prevalent and disabling syndrome characterized by sustained sadness and/or anhedonia, as well as cognitive and physical symptoms. In Parkinson's disease (PD), depression is both common and clinically challenging due to overlapping symptoms and complex etiologic interactions. Major depressive disorder occurs in approximately 17%
Albert F.G. Leentjens, Gregory M. Pontone   +1 more
wiley   +1 more source

Temporal Interference Stimulation Modulates Resting State Functional Connectivity of Motor Circuit in Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Background Transcranial temporal interference stimulation (TIs) targeting the subthalamic nucleus (STN) is a novel noninvasive neuromodulation approach with potential to improve motor symptoms in Parkinson's disease (PD). However, its underlying neuroimaging mechanisms remain unclear.
Yongxin Xu, Chenhao Yang, Yichao Du, Xiaonan Shen, Tingting Li, Yufeng Zhang, Zijun Lu, Jie Zhuang, Nan Chen, Yulian Zhu, Chencheng Zhang, Jiaojiao Lü, Lingyan Huang, Lu Li, Jianqiang Lü, Zhenyu Qian, Zhen Wang, Jian Zhang, Junhong Zhou, Yu Liu   +19 more
wiley   +1 more source

Persuasive Systems Design Features of Smartphone Apps for Psychosis: Systematic Review. [PDF]

JMIR Hum Factors
Taylor T, Peat J, Kell D, Daryan S, Jacobsen P.   +4 more
europepmc   +1 more source

Factors Associated with Early Discontinuation of Foslevodopa/Foscarbidopa in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Keita Kakuda, Yasuyoshi Kimura, Lindun Ge, Kensuke Ikenaka, Kanako Asai, Shunpei Murakami, Kotaro Ogawa, Hideki Mochizuki   +7 more
wiley   +1 more source

Heterogenous Neuropathology in a Pedigree with RAB39B‐Related Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Background In 2015, we reported a family with Parkinson's disease resulting from the RAB39B p.G192R (c.574G>A) variant. Since then, two affected brothers from the family have undergone autopsy. Objectives To characterize neuropathological findings, assess intracellular distribution of RAB39B protein, and examine the effect of p.G192R on α ...
Caitlin Latimer, Oswaldo Lorenzo‐Betancor, Dong‐Hui Chen, Kimmy Su, Marika Bogdani, Anna J. Park, Minsuh Kim, Joshua Weiss, Malia Callier, Ella H. Chiu, Sarah Fish, Jennifer L. Witt, Wendy H. Raskind, Marie Y. Davis, C. Dirk Keene, Cyrus P. Zabetian   +15 more
wiley   +1 more source

Initial physical health assessment for psychosis in Australia and New Zealand: 2026 recommendations. [PDF]

Aust N Z J Psychiatry
Warren N, O'Gorman C, Dark F, Every-Palmer S, Halstead S, Korman N, Lappin J, Lawn S, O'Donoghue B, Suetani S, Thompson A, Loi SM, Scott JG, Runnegar N, Pillinger T, McCutcheon RA, Blackman G, Skerlj T, Firman J, Siskind D.   +19 more
europepmc   +1 more source

Observations on an Open‐Label Phase 1/2 Dopamine Gene Therapy Trial (OXB‐102/Axo‐Lenti‐PD) in People with Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Background SUNRISE‐PD was a dose‐escalating, phase 1/2 study investigating a second‐generation lentiviral vector gene therapy delivering the genes for dopamine synthesis (OXB‐102) to treat Parkinson's disease (PD). The trial was prematurely terminated due to insolvency of the sponsor.
Simon Rowe, Amy Evans, Saeed Kayhanian, Philip C. Buttery, Robert Morris, Katie Andresen, Laura Sherlock, Samuel Hewitt, Tagore Nakornchai, Marwan Hariz, Kyriacos Mitrophanous, Ludvic Zrinzo, Matthew Appleby, Phil Woodgate, Seema Maru, Patricia Limousin, Christine Girges, Thomas Foltynie, Stephane Palfi, Roger A. Barker   +19 more
wiley   +1 more source

Transdiagnostic divergent neural development of reward anticipation in early adolescents at risk for depression and psychosis. [PDF]

Dev Cogn Neurosci
Huang Y, Xu H, Zhang W, Jin J, Li Y, Yan C.   +5 more
europepmc   +1 more source

Diurnal‐Only Foslevodopa/Foscarbidopa

Movement Disorders Clinical Practice, EarlyView.
Alexandra McGuckin, Yu‐Yan Poon, Galit Kleiner, Alfonso Fasano   +3 more
wiley   +1 more source